Related Experiment Video
Updated: Dec 11, 2025
Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Simvastatin induces adverse effects on proliferation and mineralization of human primary osteoblasts
Martin Mariano Isabelo Sabandal1, Edgar Schäfer2, Jonathan Aed2,3
1Central Interdisciplinary Ambulance in the School of Dentistry, University of Münster, Albert-Schweitzer-Campus 1, Gebäude W30, Waldeyerstr. 30, 48149, Münster, Germany. martin.sabandal@ukmuenster.de.
Background:
Frequently statins were administered to reduce the LDL-concentration in circulating blood. Especially simvastatin (SV) is an often prescribed statin. Pleiotropic effects of these drugs were reported. Thus, the aim of this study was to evaluate effects of SV on osteoblastic mineralization.
Methods:
After informed consent primary osteoblasts were collected from tissue surplus after treatment of 14 individuals in the Department of Cranio-Maxillofacial Surgery, University Hospital Münster. The cells were passaged according to established protocols. Viability, mineralization capability and osteoblastic marker (alkaline phosphatase) were determined at day 9, 13 and 16 after adding various SV concentrations (0.05 μM, 0.1 μM, 0.5 μM, 1.0 μM). Statistical analysis was performed using the Kruskal-Wallis-test.
Results:
The cell cultures showed a time and dose-dependent significantly decreased viability (p < 0.01) and a significantly increased mineralization (p < 0.01) in a late mineralization stage after adding SV. The typical alteration of the alkaline phosphatase (ALP) levels during osteogenic differentiation was not recognizable.
Conclusions:
The pleiotropic effects found for different SV concentrations were possibly originated from other mineralization pathways beside the ALP induced one. Additionally, possible alterations of protein expression levels during mineralization and investigation of possible deviating application of SV in other treatment fields can be considered after gaining a deeper insight in the affected mechanisms.
Insights
Simvastatin (SV) significantly decreased osteoblast viability but increased mineralization, independent of alkaline phosphatase (ALP) activity. These findings suggest SV may influence bone formation through alternative pathways, warranting further investigation into its pleiotropic effects.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Statins, particularly simvastatin (SV), are widely used to lower LDL cholesterol.
- SV exhibits pleiotropic effects beyond lipid reduction.
- The impact of SV on osteoblastic mineralization remains to be fully elucidated.
Purpose of the Study:
- To investigate the effects of simvastatin (SV) on primary osteoblast viability and mineralization.
- To explore the potential role of SV in alternative bone formation pathways.
Main Methods:
- Primary osteoblasts were isolated and treated with varying concentrations of SV (0.05–1.0 μM).
- Cell viability, mineralization capability, and alkaline phosphatase (ALP) levels were assessed at multiple time points.
- Statistical analysis was performed using the Kruskal-Wallis test.
Main Results:
- SV treatment resulted in a time- and dose-dependent decrease in cell viability (p < 0.01).
- A significant increase in mineralization was observed in later stages of culture (p < 0.01).
- The characteristic changes in alkaline phosphatase (ALP) during osteogenic differentiation were not detected.
Conclusions:
- SV's pleiotropic effects on mineralization may involve pathways independent of ALP.
- Further research is needed to understand the precise mechanisms underlying SV-induced alterations in osteoblastic cells.
- Investigating protein expression and alternative applications of SV in other therapeutic fields is recommended.
Related Concept Videos
01:25Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:31Osteoclasts in Bone Remodeling
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:31Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...